Vitanova Biomedical, Inc. (VNB) products

Vitanova Biomedical’s Cancer Therapy Technology Platform is Called Light-Activated Intracellular Acidosis (LAIA). Vitanova Biomedical (VNB) has developed a proprietary energy-based technique to elicit cancer-specific intracellular acidosis. The foundation of VNB’s core technology combines three proven principles accepted in today’s cancer therapeutics: Intracellular acidosis kills cancer cells. Compounds can be activated by specific wavelengths of light. Nanoparticles can be actively targeted to only cancer using antibody/antigen conjugation.